Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, 100053, China
NCT Number: NCT03786666
The purpose of this multiple-center study are: 1) To establish the ultrasound criteria for evaluating vulnerable plaques by comparing the plaque echo characteristics before CEA (carotid artery endarterectomy) and plaque specimen after CEA.
2) To establish the carotid artery recanalization strategies based on the evaluation results of carotid artery and intracranial artery by color doppler flow imaging and TCCS/TCD (transcranial color coded sonography/transcranial doppler).
3) To compare the success rate and the incidence of restenosis between CEA and carotid artery stenting.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Beijing, Beijing Municipality, 100053, China
In this study, a total of 1000-1200 patients with carotid artery moderate (50-69%, with symptoms), severe (70-99%) stenosis (with or without symptoms) or occlusion who received either CEA or stenting are to recruited. Before carotid artery recanalization, CDFI (color duplex flow imaging) and TCCS/TCD are used to evaluate the structures and hemodynamic of carotid artery and intracranial artery. In addition, patients are to be followed up by ultrasound 1 week, 3 month, 6month and 1 year after recanalization.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Carotid artery recanalization CEA or carotid artery stenting
Time frame: within 30-day after recanalization.
The rate of combination endpoints events, including death, cerebral hemorrhage , newly cerebral infarction, hyperperfusion syndrome, and residual sternosis≥50%
Time frame: during the at least 1 year follow-up period
the rate of re-current cerebral artery events and the occurence of restenosis
Xuanwu Hospital, Beijing
Other
Vascular Ultrasound Evaluation of Atherosclerotic Plaques and the Success of Recanalization in Patients With Carotid Artery Stenosis and Occlusion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05935670
Brain Diseases, Cardiovascular Diseases
Milwaukee, Wisconsin, United States
View Trial DetailsNCT06251661
Brain Diseases, Cardiovascular Diseases
Cairo, Giza Governorate, Egypt
View Trial DetailsNCT05349526
Arterial Occlusive Diseases, Brain Diseases
Nîmes, France
View Trial DetailsNCT00597883
Arterial Occlusive Diseases, Brain Diseases
New York, United States
View Trial Details